New Diagnoses Don't Close the Book

Both patients in Brazil being monitored for Ebola have now tested positive for something else. The 37-year-old man from the Democratic Republic of Congo in São Paulo tested positive for meningitis and is in serious condition, according to BBC News. The Belgian man in Rio de Janeiro, who arrived from Uganda, tested positive for malaria.

Brazilian health officials are explicitly saying these diagnoses do NOT rule out simultaneous Ebola infection. Ebola test results for both patients are expected next week.

Co-infections are documented in viral outbreaks. A sick traveler from an active outbreak zone testing positive for one disease does not necessarily mean that is the only disease they have.

The Outbreak Numbers Keep Moving

According to the World Health Organization, the Congo outbreak has now recorded more than 1,000 suspected and confirmed cases, with at least 246 deaths — up from the 223 deaths cited in earlier WHO figures reported by NPR as of May 31, 2026. Health workers on the ground told NPR that even those numbers are likely a major undercount.

Uganda, which borders Congo, has reported nine confirmed cases and one death, according to BBC News. On May 27, Uganda closed its official border crossings with Congo — but Leonard Musinguzi, a community and surveillance officer for the International Rescue Committee in Uganda, told NPR that porous border points still exist and people are still crossing.

The Strain Nobody Has a Vaccine For

This outbreak is caused by the Bundibugyo strain of Ebola, according to BBC News. There is NO proven vaccine for it. It kills roughly one in three people infected.

For context, the more famous Zaire strain — the one most people picture when they think Ebola — does have an approved vaccine. Bundibugyo does not. Most mainstream coverage does not emphasize this distinction.

Aid Cuts Are Gutting the Frontline

NPR reported directly on what U.S. foreign aid cuts are doing to the people trying to stop this outbreak before it spreads further.

Musinguzi's IRC team runs public health messaging across Uganda — radio spots, posters, hospital TV content designed to counter Ebola misinformation. Before the cuts, his team could buy time on five radio talk shows. Now? One.

"Because of this reduced funding, you only have one," Musinguzi told NPR.

Social media misinformation is already claiming Ebola isn't real, or that health workers are there to profit. Musinguzi is fighting that misinformation with a fraction of the budget he had before.

The U.S. was spending significant money on global health infrastructure, and cutting it has real-world consequences that play out in scenarios like this one. Fewer radio spots means fewer informed villagers, which means harder contact tracing and faster potential spread.

Questions remain about whether the previous spending was structured efficiently, whether programs were producing measurable results, and whether other donor nations should be stepping up.

What Mainstream Coverage Is Getting Wrong

Most coverage is treating the Brazil cases as either a confirmed scare or a near-miss. Neither framing is accurate yet. Test results are pending. The answer remains unknown.

AP News headlined WHO's announcement of five Ebola recoveries in Congo and a new treatment center opening — genuine developments. But framing recoveries as the lead story while the death toll sits at 246 and climbing shifts the narrative.

NPR's reporting on aid cuts is the most substantial journalism on this story, though it does not explore whether pre-cut spending levels were optimal or whether recipient-country governments bear responsibility for their own public health infrastructure.

What Happens Next

If either Brazil case confirms positive, Ebola will have its first documented spread outside Africa in this outbreak — crossing the Atlantic via commercial travel. That changes the calculus for every country with international air traffic.

For now: the disease is contained in Africa, the death toll is rising, the strain has no vaccine, the border controls are porous, misinformation is spreading, and the funding to combat it has been cut.

Brazil's test results next week will be the critical data point to watch.